1-20 of 24
Curtis A Lachowiez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic Diversity Drives Differing Morphological and Clinical Presentation and Survival in Myelodysplastic-Type CMML with a Low Absolute Monocyte Count

Curtis A Lachowiez, Georgios Asimomitis, Elsa Bernard, Yanis Tazi, Maria Creignou, Ulrich Germing, Norbert Gattermann, Amanda Gilkes, Ian Thomas, Lars Bullinger, Konstanze Döhner, Luca Malcovati, Nigel H. Russell, Mario Cazzola, Hartmut Döhner, Brian J P Huntly, Robert P Hasserjian, Eva Hellstrom Lindberg, Sanam Loghavi, Elli Papaemmanuil
Journal: Blood
Blood (2024) 144 (Supplement 1): 1830.
https://doi.org/10.1182/blood-2024-209450
Published: 2024
Journal Articles

NCAM1 (CD56) As a Predictor of Response to Standard Intensive Induction in Newly Diagnosed Acute Myeloid Leukemia

Jennifer N. Saultz, Manoj Rai, Andy Kaempf, Sanjog Bastola, Hyun Cho, Nicola Long, Curtis A. Lachowiez, Gabrielle Meyers, Jessica T. Leonard, Arpita Gandhi, Laura F. Newell, Brandon Hayes-Lattin, Richard T. Maziarz, Rachel J. Cook, Elie Traer, Ronan T. Swords, Jeffrey W. Tyner
Journal: Blood
Blood (2024) 144 (Supplement 1): 2859.
https://doi.org/10.1182/blood-2024-211860
Published: 2024
Journal Articles

Outcomes By Frailty in IC-Ineligible Newly Diagnosed AML - a Real-World Evidence Comparison By Treatment with Hypomethylating Agents + Ivosidenib or Venetoclax

B. Douglas Smith, Curtis A. Lachowiez, Alexander J. Ambinder, Gary Binder, Anne Angiolillo, Ravi Potluri, Eros Papademetriou, Thomas W. LeBlanc
Journal: Blood
Blood (2024) 144 (Supplement 1): 2855.
https://doi.org/10.1182/blood-2024-210603
Published: 2024
Journal Articles

Impact of Social Determinants of Health on Access to Blood and Marrow Transplantation for Acute Myeloid Leukemia

Somya Khare, Rachel J. Cook, Amrita Desai, Arpita Gandhi, Kelli Goslee, Brandon Hayes-Lattin, Curtis A Lachowiez, Jessica T. Leonard, Richard T. Maziarz, Gabrielle Meyers, Laura F. Newell, Jennifer N. Saultz, Ronan T. Swords, Elie Traer, Eneida R Nemecek
Journal: Blood
Blood (2024) 144 (Supplement 1): 2292.
https://doi.org/10.1182/blood-2024-209407
Published: 2024
Journal Articles

A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Hematologic Malignancies: A 2024 Update

Jennifer Marvin-Peek, Jacqueline S. Garcia, Gautam Borthakur, Guillermo Garcia-Manero, Nicholas J. Short, Tapan M. Kadia, Sanam Loghavi, Lucia Masarova, Naval Daver, Abhishek Maiti, Koichi Takahashi, Koji Sasaki, Danielle Hammond, George Donovan Tippett, Dylan Wilson, Kelly S. Chien, Prithviraj Bose, Patrick K. Reville, Curtis A Lachowiez, Akriti G. Jain, Ghayas C. Issa, Nitin Jain, Guillermo Montalban-Bravo, Marlise R. Luskin, Hetty E. Carraway, Farhad Ravandi, Hagop M. Kantarjian, Courtney D. DiNardo
Journal: Blood
Blood (2024) 144 (Supplement 1): 219.
https://doi.org/10.1182/blood-2024-200393
Published: 2024
Journal Articles

Influence of AML Differentiation State in Risk Stratification of Frontline Therapy with Hypomethylating Agents + Venetoclax in AML

Curtis A Lachowiez, Joshua F Zeidner, Ashley M. Eckel, Daniel T Peters, Jacob Fang, Amenech Ashango, Andy Kaempf, Fangyan Dai, Christopher A. Eide, Stephen E. Kurtz, Theodore P Braun, Ronan T. Swords, Jennifer N. Saultz, Jeffrey W. Tyner, Daniel A Pollyea
Journal: Blood
Blood (2024) 144 (Supplement 1): 62.
https://doi.org/10.1182/blood-2024-201532
Published: 2024
Journal Articles

Clonal Basis of Resistance and Response to Ivosidenib Combination Therapies Is Established Early during Treatment in IDH1 -Mutated Myeloid Malignancies

Sven Turkalj, Bilyana Stoilova, Angus J Groom, Felix A Radtke, Rabea Mecklenbrauck, Niels Asger Jakobsen, Curtis A Lachowiez, Marlen Metzner, Batchimeg Usukhbayar, Mirian Angulo Salazar, Zhihong Zeng, Sanam Loghavi, Jennifer Marvin-Peek, Verena Körber, Farhad Ravandi, Ghayas C. Issa, Tapan M. Kadia, Vasiliki Symeonidou, Anne De Groot, Hagop M. Kantarjian, Koichi Takahashi, Marina Konopleva, Courtney D. DiNardo, Paresh Vyas
Journal: Blood
Blood (2024) 144 (Supplement 1): 642.
https://doi.org/10.1182/blood-2024-201970
Published: 2024
Journal Articles

Immunophenotypic Markers CD7 and CD56 Improve Risk Stratification of Frontline Hypomethylating Agents + Venetoclax in Newly Diagnosed AML

Curtis A Lachowiez, Daniel T Peters, Jacob Fang, Andy Kaempf, Jessica T. Leonard, Laura F. Newell, Arpita Gandhi, Gabrielle Meyers, Brandon Hayes-Lattin, Richard T. Maziarz, Rachel J. Cook, Elie Traer, Ronan T. Swords, Jeffrey W. Tyner, Joshua F Zeidner, Daniel A Pollyea, Jennifer N. Saultz
Journal: Blood
Blood (2024) 144 (Supplement 1): 4314.
https://doi.org/10.1182/blood-2024-202118
Published: 2024
Journal Articles

Purine-Analog Based Intensive Chemotherapy (IC) Combined with Venetoclax (VEN) Is Highly Active in Newly Diagnosed (ND) and Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Curtis A Lachowiez, Adam Julian Cohen-Nowak, Talha Khan, Joanna Cwykiel, Bukky Florence Tabiti, Irum Khan, Shira N. Dinner, Justin Grenet, Aya Agha, Jennifer N. Saultz, Arpita Gandhi, Gabrielle Meyers, Laura F. Newell, Jessica T. Leonard, Brandon Hayes-Lattin, Elie Traer, Richard T. Maziarz, Rachel J. Cook, Ronan T. Swords, Jessica Kaplan Altman, Yasmin Abaza
Journal: Blood
Blood (2024) 144 (Supplement 1): 2887.
https://doi.org/10.1182/blood-2024-203361
Published: 2024
Journal Articles

Clinical Outcomes Using Frontline “Triplet” Regimens for Newly Diagnosed IDH -Mutated Acute Myeloid Leukemia (AML): A Pooled Analysis of Two Phase Ib/2 Clinical Trials

Jennifer Marvin-Peek, Himachandana Atluri, Nicholas J. Short, Abhishek Maiti, Koichi Takahashi, Sanam Loghavi, Curtis A Lachowiez, Yesid Alvarado Valero, Guillermo Montalban-Bravo, Koji Sasaki, Fadi G. Haddad, Ghayas C. Issa, Lucia Masarova, Hussein A. Abbas, Michael Andreeff, Gautam Borthakur, Jillian Mullin, George Donovan Tippett, Kelly S. Chien, Danielle Hammond, Jo Ishizawa, Nitin Jain, Patrick K. Reville, Mahesh Swaminathan, Musa Yilmaz, Naval Daver, Tapan M. Kadia, Farhad Ravandi, Guillermo Garcia-Manero, Hagop M. Kantarjian, Courtney D. DiNardo
Journal: Blood
Blood (2024) 144 (Supplement 1): 2883.
https://doi.org/10.1182/blood-2024-200387
Published: 2024
Journal Articles

Phase 1 Trial Testing the Novel Combination Therapy of Entrectinib and ASTX727 in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia Patients

Cristina Tognon, Shikha Mishra, Andy Kaempf, Byung Park, Sunil K Joshi, Ariane Huang, Stephen E. Kurtz, Luca Sax, Christopher A. Eide, Kara Johnson, Rachel Mahoney, Michael James Lue, Nicole Tong, Lisa Guiducci, Tara Lundberg Willians, Emma Indira Solanki, Rachel J. Cook, Jessica T. Leonard, Curtis A Lachowiez, Gabrielle Meyers, Jennifer N. Saultz, Elie Traer, Jeffrey W. Tyner, Uma Borate, Ronan T. Swords
Journal: Blood
Blood (2024) 144 (Supplement 1): 1498.
https://doi.org/10.1182/blood-2024-208505
Published: 2024
Journal Articles

PTPN11 Mutations Are Associated with Shorter Survival in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax

Vishvaas I Ravikumar, Jessica T. Leonard, Laura F. Newell, Arpita Gandhi, Gabrielle Meyers, Brandon Hayes-Lattin, Richard T. Maziarz, Rachel J. Cook, Elie Traer, Ronan T. Swords, Jennifer N. Saultz, Jeffrey W. Tyner, Mael Heiblig, Joshua F Zeidner, Daniel A Pollyea, Curtis A Lachowiez
Journal: Blood
Blood (2024) 144 (Supplement 1): 4312.
https://doi.org/10.1182/blood-2024-201231
Published: 2024
Journal Articles

Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML

Curtis A. Lachowiez, Vishvaas I Ravikumar, Jad Othman, Jenny O'Nions, Daniel T Peters, Christine McMahon, Ronan Swords, Rachel Cook, Jennifer N. Saultz, Jeffrey W. Tyner, Richard James Dillon, Joshua F. Zeidner, Daniel A. Pollyea
Journal: Blood
Blood blood.2024026925.
https://doi.org/10.1182/blood.2024026925
Published: 2024
Includes: Supplemental data
Journal Articles

Acute Myeloid Leukemia Differentiation State and Genotype Influence Anti-Apoptotic Protein Expression, Venetoclax Sensitivity, and Survival in AML

Curtis A. Lachowiez, Christopher A. Eide, Stephen E. Kurtz, Nicola Long, Manoj Rai, Wei Xie, Andy Kaempf, Daniel Bottomly, Rachel Cook, Gabrielle Meyers, Arpita Gandhi, Jessica T. Leonard, Brandon Hayes-Lattin, Laura F. Newell, Richard T Maziarz, Jennifer N. Saultz, Elie Traer, Theodore P Braun, Ronan T. Swords, Shannon K McWeeney, Jeffrey W Tyner
Journal: Blood
Blood (2023) 142 (Supplement 1): 978.
https://doi.org/10.1182/blood-2023-179527
Published: 2023
Journal Articles

A Phase I/II Study to Investigate the Addition of Venetoclax to Dasatinib and Steroids in Patients with Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL): The Venda Trial, in Progress

Jessica T. Leonard, Rachel Cook, Laura F. Newell, Arpita Gandhi, Ronan T. Swords, Christopher A. Eide, Brandon Hayes-Lattin, Kara Johnson, Elie Traer, Stephen E. Kurtz, Jennifer N. Saultz, Cristina Tognon, Jeffrey W Tyner, Curtis A. Lachowiez
Journal: Blood
Blood (2023) 142 (Supplement 1): 1512.
https://doi.org/10.1182/blood-2023-188313
Published: 2023
Journal Articles

A Rapid Test to Evaluate the Tumor Differentiation State of Acute Myeloid Leukemias

Stephen E. Kurtz, Christopher A. Eide, Nicola Long, Daniel Bottomly, Shannon K McWeeney, Akosha Taylor, Brian J. Druker, Sudarshan Anand, Curtis A. Lachowiez, Jeffrey W Tyner
Journal: Blood
Blood (2023) 142 (Supplement 1): 3643.
https://doi.org/10.1182/blood-2023-180105
Published: 2023
Journal Articles

The Significance of Variant Allele Frequency in SF3B1 Mutated Myelodysplastic Neoplasms/Syndromes

Curtis A. Lachowiez, Georgios Asimomitis, Elsa Bernard, Ivory Tang, Maria Creignou, Ulrich Germing, Norbert Gattermann, Luca Malcovati, Mario Cazzola, Eva Hellstrom Lindberg, Elli Papaemmanuil, Sanam Loghavi
Journal: Blood
Blood (2023) 142 (Supplement 1): 1870.
https://doi.org/10.1182/blood-2023-179899
Published: 2023
Journal Articles

Influence of Bone Marrow Blast Enumeration and Co-Occurring Myelodysplasia Related Gene Mutations in NPM1 -Mutated Myeloid Malignancies

Curtis A Lachowiez, Georgios Asimomitis, Elsa Bernard, Ivory Tang, Yanis Tazi, Amanda Gilkes, Ian Thomas, Lars Bullinger, Konstanze Döhner, Hartmut Dohner, Brian Huntly, Nigel H. Russell, Sanam Loghavi, Elli Papaemmanuil
Journal: Blood
Blood (2023) 142 (Supplement 1): 818.
https://doi.org/10.1182/blood-2023-179598
Published: 2023
Journal Articles

A Comparison of Acute Myeloid Leukemia (AML) Regimens: Hypomethylating Agents Combined with Ivosidenib or Venetoclax in Newly Diagnosed Patients with IDH1 Mutations: A Real-World Evidence Study

B. Douglas Smith, Curtis A Lachowiez, Alexander Joseph Ambinder, Gary Binder, Anne Angiolillo, Assaf Vestin, Robert Paglia, Ravi Potluri, Eros Papademetriou, Thomas W LeBlanc
Journal: Blood
Blood (2023) 142 (Supplement 1): 971.
https://doi.org/10.1182/blood-2023-173033
Published: 2023
Journal Articles

Thromboprophylaxis with Intermediate Dose Low Molecular Weight Heparin in Adults Undergoing Induction with L-Asparaginase for Acute Lymphoblastic Leukemia

Hong De Sa, Thomas G Deloughery, Curtis A Lachowiez, Jessica T. Leonard, Sven R. Olson, Joseph J. Shatzel, Ronan T. Swords, Elie Traer, Brandon Hayes-Lattin
Journal: Blood
Blood (2023) 142 (Supplement 1): 2829.
https://doi.org/10.1182/blood-2023-178918
Published: 2023